Innovation Pharmaceuticals Inc (IPIX)

[Patientspeople]

Are the stars, moon and planet finally aligning????

1. Great timing is everything (check) Huge Unmet Need Worldwide - Brilacidin has been granted FDA Fast Track designation and currently is being evaluated in a randomized, placebo-controlled Phase 2 clinical trial in hospitalized COVID-19 patients.

2. Who you know is game changer (check) Dr. William DeGrado and his connections from UCSF

3. Having an Therapeutic with it's novel MOA (check) "Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture”— in the journal Viruses that supports Brilacidin’s potential as a COVID-19 treatment."

Vaccines cannot handle some of the newer mutations ... look it up.... they are not all that we all hoped for! The Covid-19 Vaccines cannot keep up with the many mutations that are taking place as we speak.
Brilacidin is a very unique therapeutic that can handle all comers and is not subject to resistance.